比梅基祖马布用于治疗牛皮
Molly Thapar1, Milan Patel1, Kenneth Gordon2
1Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 532261, USA.
Immunotherapy
|March 20, 2024
概括
针对IL-17A和IL-17F的新型牛皮治疗方法Bimekizumab在临床试验中显示出强大的安全性和有效性. 它为牛皮患者提供快速,持续的症状缓解.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 炎症性皮肤疾病是一种炎症性皮肤疾病.
- 皮肤病学中的生物药物.
背景情况:
- 牛皮是一种由T助手17 (Th17) 细胞驱动的慢性炎症性皮肤疾病.
- 干白素-17 (IL-17) 细胞因子,特别是IL-17A和IL-17F,在牛皮病原发生过程中起着关键作用.
- 目前的治疗方法旨在调节这些炎症途径.
研究的目的:
- 评估比梅奇祖马布在治疗牛皮方面的安全性,耐受性和临床疗效.
- 评估不同剂量方案对不良事件和疗效的影响.
- 探索比梅奇祖马布在其他Th17介导疾病中的潜力.
主要方法:
- 进行了I,II和III期的临床试验,以评估bimeqizumab.
- 在整个试验中,监测了安全性和耐受性.
- 临床疗效与安慰剂和活性比较剂进行了比较,使用了各种结局措施.
- 进行了开放式扩展研究,以评估长期反应.
主要成果:
- 比梅基祖马布表现出强大的安全性,治疗后出现轻度至中度的不良事件.
- 较高剂量或更频繁的使用显示不良事件的增加很小.
- 与安慰剂和活性比较剂相比,观察到显著和持续的临床反应.
- 在有效性评估中,人们注意到作用的迅速开始.
结论:
- 比梅基祖马布是适度至重症牛皮的安全有效治疗选择.
- 该药物提供了快速和持续的临床改善.
- 比梅基祖马布有望治疗与Th17介导炎症相关的其他疾病.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
118
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
01:29Drugs for Treatment of Ulcerative Colitis in IBD
139
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
139
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127